Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Mar 1, 2018 · 10-K · 60 days after period end · 0001564590-18-004159
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Net Income | -$3.74M | -$486.00K | -$1.72M | -$5.68M |
| EPS Diluted | -$3.17 | -$22.89 | $0.06 | -$0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 1, 2018 · 60 d after period end
